C
씨엑스아이
900120KOSDAQ48.5 / 100
Reference Date: 2026-10-23
Financial Score13.0 / 40
News Sentiment12.5 / 25
Momentum13.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Surged 222.1% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
CXI focuses on the production and sales of health foods in China, capitalizing on the rapidly growing Chinese health food market. While the market shows significant growth potential, challenges such as insufficient R&D investment, over-advertising, and counterfeit products remain notable issues.
Number of Employees
—
Average Salary
—
Score Calculation Basis
Detailed Financial Score
PER
578.29Industry Average 15.000.0Point
38.6x industry avg (risky)
PBR
14.61Industry Average 1.200.0Point
12.2x industry avg (risky)
ROE
2.56Industry Average 8.001.0Point
Well below industry avg
Debt Ratio
0.11Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20254.0 / 10 points
Revenue Growth Rate
0.0 / 3
Avg ▼10.6% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲60.8% (2-year basis)
ROE Trend
1.0 / 4
Avg ROE 3.7% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position6.0Point
52w upper range (64%)
Current 3,350Won52-week high 4,99052-week low 352
1-month return6.0Point
1m +222.12% (strong rise)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
15 totalPositive 0Neutral 15Negative 0
- Neutral[기재정정]주요사항보고서(타법인주식및출자증권양수결정)2026-10-22
- Neutral외국지주회사의자회사편입ㆍ탈퇴2026-10-22
- Neutral[기재정정]주주총회소집공고2026-10-20
- Neutral[기재정정]의결권대리행사권유참고서류2026-10-20
- Neutral감사보고서제출2026-10-20